Abstract
Renal denervation (RDN) for the treatment of resistant hypertension has been shown in pilot studies to lower blood pressure (BP) without safety alerts. However, this was only shown in open la-belled study designs and has primarily addressed the effect on office BP. We therefore conducted a sham
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
